← Krystal Biotech, Inc. KRYS
Market Price
$332.07
Market Cap
$9.69B
P/E Ratio
48.55
Revenue (FY 2025)
↑33.9% YoY
$389.13M
Full year reported
Net Income
↑129.7% YoY
$204.83M
Net Margin: 52.6%
Free Cash Flow
↑58.5% YoY
$188.91M
FCF Yield: 1.95%
EPS (Diluted)
↑128.0% YoY
$6.84
Basic: $7.08
Return on Equity
Efficiency
16.8%
ROA: 1,374.2%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (KRYS)
All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
- FY 2019: Revenue YoY (+300.0%) is identical to Gross Profit YoY (+300.0%). Verify the underlying Revenue and Gross Profit values for FY 2019 and FY 2018.
| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | — | — | — | $-1.1M | — | $-1.31 | — | $-1.3M | $-1.3M | — |
| FY 2017 | — | — | — | $-7.9M | -588.7% | $-1.48 | -13.0% | $-3.9M | $-4.1M | -209.2% |
| FY 2018 | $0.0M | — | $0.0M | $-10.9M | -37.5% | $-0.97 | +34.5% | $-9.4M | $-11.7M | -184.9% |
| FY 2019 | $0.0M | +300.0% | $0.0M | $-19.1M | -75.3% | $-1.20 | -23.7% | $-18.7M | $-25.1M | -115.0% |
| FY 2020 | $-0.0M | -150.0% | — | $-32.2M | -68.5% | $-1.71 | -42.5% | $-26.1M | $-40.9M | -63.0% |
| FY 2021 | — | +100.0% | — | $-69.6M | -116.3% | $-3.13 | -83.0% | $-47.9M | $-116.3M | -184.1% |
| FY 2022 | — | — | — | $-140.0M | -101.2% | $-5.49 | -75.4% | $-100.6M | $-153.5M | -32.1% |
| FY 2023 | $50.7M | — | $47.6M | $10.9M | +107.8% | $0.39 | +107.1% | $-88.8M | $-100.6M | +34.5% |
| FY 2024 | $290.5M | +473.0% | $270.5M | $89.2M | +715.6% | $3.00 | +669.2% | $123.4M | $119.2M | +218.5% |
| FY 2025 | $389.1M | +33.9% | $366.1M | $204.8M | +129.7% | $6.84 | +128.0% | $200.9M | $188.9M | +58.5% |
Valuation
Market Price
$332.07
Market Cap
$9.69B
Enterprise Value
N/A
P/E Ratio
48.55
P/B Ratio
8.03
FCF Yield
1.95%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
94.08%
Operating Margin
41.45%
Net Margin
52.64%
Return on Equity (ROE)
16.80%
Return on Assets (ROA)
1,374.24%
Asset Turnover
26.11x
Revenue 3-Yr CAGR
N/A
Financial Health & Liquidity
Current Ratio
0.14
Cash Ratio
4.82
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$496.30M
Total Debt
N/A
Book Value / Share
$41.37
Cash Flow Efficiency
Operating Cash Flow
$200.87M
Capital Expenditures (CapEx)
$11.95M
Free Cash Flow
$188.91M
OCF / Revenue
51.62%
FCF / Revenue
48.55%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$6.84
EPS (Basic)
$7.08
Dividends / Share
N/A
Book Value / Share
$41.37
EPS YoY Growth
128.00%
Balance Sheet (FY 2025)
Total Assets
$14.90M
Total Liabilities
$102.94M
Stockholders' Equity
$1.22B
Current Assets
$14.90M
Current Liabilities
$102.94M